-+ 0.00%
-+ 0.00%
-+ 0.00%

MAAT PHARMA RECEIVES NEGATIVE CHMP TREND VOTE FOR MAAT013 (XERVYTEG®) FOLLOWING RE-EXAMINATION FOR ITS CONDITIONAL MARKETING AUTHORIZATION APPLICATION IN EUROPE

路透·09/15/2026 05:30:00

登录查看新闻详情